HESI LPN
LPN Nutrition Practice Test
1. What should be monitored in a child receiving chemotherapy?
- A. Blood glucose levels
- B. Blood cell counts
- C. Weight gain
- D. Skin elasticity
Correct answer: B
Rationale: The correct answer is monitoring blood cell counts. During chemotherapy, it is crucial to monitor blood cell counts to detect potential side effects such as neutropenia (low white blood cell count) and anemia (low red blood cell count). These conditions can increase the risk of infections and fatigue. Monitoring blood glucose levels (Choice A) is not typically a primary concern in children receiving chemotherapy unless they have pre-existing conditions like diabetes. Weight gain (Choice C) and skin elasticity (Choice D) are not directly related to monitoring the effects of chemotherapy in children. Therefore, the most important parameter to monitor in a child receiving chemotherapy is blood cell counts.
2. What is a key dietary consideration for a child with phenylketonuria (PKU)?
- A. High-fiber diet
- B. Low-phenylalanine diet
- C. Increased dairy intake
- D. High-sodium diet
Correct answer: B
Rationale: A low-phenylalanine diet is crucial for managing PKU to prevent neurological damage and maintain normal development. Phenylalanine is an amino acid found in protein-containing foods, and individuals with PKU have difficulty metabolizing it. Consuming foods low in phenylalanine helps prevent the buildup of toxic byproducts in the body. Choices A, C, and D are incorrect. A high-fiber diet, increased dairy intake, and high-sodium diet are not specific dietary considerations for PKU management. In fact, dairy products are a source of protein and phenylalanine, which should be limited in PKU.
3. What is one major weakness of a laboratory-based study?
- A. The costs are typically prohibitive.
- B. Findings are difficult to replicate.
- C. Results from animal testing cannot be applied to human beings.
- D. Experimental variables cannot be easily controlled.
Correct answer: C
Rationale: One major weakness of laboratory-based studies is that results from animal testing cannot always be applied to human beings. This limitation arises due to the inherent biological differences between animals and humans, making the generalization of findings challenging. While costs may be a concern in some cases, they do not represent a universal weakness of laboratory-based studies. Findings in such studies can be replicated to ensure validity, and experimental variables can be effectively controlled in a laboratory setting. Choice C is the correct answer because the translatability of results from animal studies to humans is a significant challenge in laboratory-based research, impacting the direct application of findings to human health and well-being.
4. How should the nurse manage a child with acute lymphoblastic leukemia (ALL) who is receiving chemotherapy?
- A. Avoid all physical activity
- B. Ensure strict infection control measures
- C. Increase daily caloric intake
- D. Limit fluid intake
Correct answer: B
Rationale: The correct answer is B: Ensure strict infection control measures. Children with acute lymphoblastic leukemia (ALL) who are undergoing chemotherapy have compromised immune systems, making them highly susceptible to infections. Implementing strict infection control measures, such as hand hygiene, limiting exposure to sick individuals, and maintaining a clean environment, is essential to prevent infections. Choice A is incorrect because avoiding all physical activity may not be necessary as long as the child's activity level is appropriate. Choice C is incorrect because increasing daily caloric intake is important to support the child's nutritional needs during treatment. Choice D is incorrect because limiting fluid intake is not typically recommended unless specifically advised by the healthcare provider.
5. What is a common sign of congenital hip dysplasia in infants?
- A. Symmetrical hip movement
- B. Limited range of motion in the hip
- C. Swelling of the knees
- D. Dislocated patella
Correct answer: B
Rationale: Limited range of motion in the hip, often noted as a limitation in abduction, is a common sign of congenital hip dysplasia. This limitation is due to the abnormal development of the hip joint, affecting its movement. Symmetrical hip movement (Choice A) is not a characteristic sign of congenital hip dysplasia. Swelling of the knees (Choice C) is not typically associated with this condition. Dislocated patella (Choice D) refers to a different anatomical structure and is not a common sign of congenital hip dysplasia.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access